Ranferon-12 tonic mitigates haematological abnormalities in cyclophosphamide-treated rats
Nigerian Journal of Biochemistry and Molecular Biology · 2024
DOI: 10.4314/njbmb.v39i1.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nigerian Journal of Biochemistry and Molecular Biology, 2024. Verfasst von Azubuike I. Okafor. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cyclophosphamide (CPA) has anticancer property with many side-effects including haematotoxicity while ranferon-12 tonic (RFT) possesses haematinic effect. This study investigated the mitigating effects of RFT on haematotoxicity in CPA-treated rats. Twenty-four animals were grouped into four (n=6) and treated orally as indicated: Group A: (Control) received 0.4 mL of physiological saline (PS) for 7 consecutive days; Group B: (CPA) received 0.4 mL of PS for 7 days followed by a single intraperitoneal dose of CPA (200 mg/kg) on the 7th day; Group C: (RFT) received RFT at 0.029 mL/kg for 7 days; Group D: (RFT+CPA) received RFT at 0.029 mL/kg for 7 days followed by a single intraperitoneal dose of CPA on the 7th day. Twenty-four hours after the final treatment, the animals were weighed, anaesthetised and sacrificed. Blood was obtained via cardiac puncture and transferred to EDTA and plain tubes for further analysis. Result showed that a single dose of CPA (200 mg/kg) significantly (p < 0.05) reduced the level of white blood cells, haemoglobin, red blood cells, packed cell volume, and platelet (values >36%). Additionally, the body temperature was significantly (p
Zitieren
APA
Okafor, A. I. (2024). Ranferon-12 tonic mitigates haematological abnormalities in cyclophosphamide-treated rats. Nigerian Journal of Biochemistry and Molecular Biology. https://doi.org/10.4314/njbmb.v39i1.3
Vancouver
Okafor AI. Ranferon-12 tonic mitigates haematological abnormalities in cyclophosphamide-treated rats. Nigerian Journal of Biochemistry and Molecular Biology. 2024. doi:10.4314/njbmb.v39i1.3
BibTeX
@article{Okafor2024,
author = {Okafor, Azubuike I.},
title = {Ranferon-12 tonic mitigates haematological abnormalities in cyclophosphamide-treated rats},
journal = {Nigerian Journal of Biochemistry and Molecular Biology},
year = {2024},
doi = {10.4314/njbmb.v39i1.3}
}
EUVIMED